Luigi Mansi

Centro Interuniversitario di Ricerca Per lo Sviluppo sostenibile — Italy

Medicine · Health Sciences

39h-index5.9kcitations514works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(154), Radiomics and Machine Learning in Medical Imaging(66), Radiopharmaceutical Chemistry and Applications(64), Medical Imaging and Pathology Studies(35), Neuroendocrine Tumor Research Advances(30)

Publications513 total

Kalevi Kairemo. Prostate cancer from a nuclear oncology perspective. A personal journey. Springer Nature Switzerland AG 2025, ISBN: 978-3-031-90336-6
European Journal of Nuclear Medicine and Molecular Imaging·2026
Living longer, living better: PSMA-PET insights
Clinical and Translational Imaging·2026
Investigating the Performance of X-ray Protection of Various Elements and Alloy Compounds in Aprons for Interventional Radiology
Advanced Biomedical Research·2025Open Access
Santiago Martínez-Jiménez, Melissa L. Rosado-de-Christenson, Sherief Garrana. Specialty imaging: HRCT of the lung, 3rd edition, elsevier, 2025. ISBN 9780443286360
European Journal of Nuclear Medicine and Molecular Imaging·2025
The MIBI is dead, long live the MIBI: revisiting [99mTc]Tc-Sestamibi thyroid scintigraphy in the era of ultrasound, cytology, molecular diagnostic, and 18 F-FDG PET/CT
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
The relationship between auditory processing disorder and articulation disorders
PLoS ONE·2025· 1 citedOpen Access
Jeffrey S. Ross, Kevin R. Moore. Diagnostic imaging: spine 5th edition. Elsevier, 2025 ISBN: 9780443378812
European Journal of Nuclear Medicine and Molecular Imaging·2025
Vania Nosé. Diagnostic pathology: familial cancer syndromes, 3rd edition Elsevier 2025 ISBN: 9780443286407
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
1123P Efficacy and safety of pembrolizumab–lenvatinib in metastatic endometrial cancer: Results from the French multicenter early access program (LARENA)
Annals of Oncology·2025
618TiP Phase I/II study of tuvusertib, an ATR inhibitor in combinaison with fulvestrant in hormone receptor-positive and HER2-negative, advanced breast cancers, resistant to CDK4/6 inhibitors plus aromatase inhibitor-based endocrine treatments and in various molecular contexts (MATRIx)
Annals of Oncology·2025
PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life
European Journal of Nuclear Medicine and Molecular Imaging·2025· 1 citedOpen Access
European Nuclear Medicine Guide - update 2026
2025
Lee A. Grant & Nyree Griffin (Authors). Grainger & Allison’s Diagnostic Radiology Essentials, 3rd Edition. Elsevier, 2025, ISBN: 978-0-323-93605-7
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
10O Efficacy according to PD-L1 status in the BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) randomised phase III trial of first-line atezolizumab (atezo), chemotherapy (CT) and bevacizumab (bev) for metastatic, persistent or recurrent cervical cancer (R/M CC)
ESMO Open·2025Open Access
James F. Griffith. Diagnostic ultrasound: musculoskeletal, 3rd edition. Elsevier, 2025, ISBN: 9780443285646
European Journal of Nuclear Medicine and Molecular Imaging·2025
C.G. Roth, H. Naringrekar, S. Deshmukh. Fundamentals of body MRI, 3rd Edition. Elsevier, 2025. ISBN: 97,803,323,833,813
European Journal of Nuclear Medicine and Molecular Imaging·2025Open Access
Abdelhamid H. Elgazzar. Orthopedic Nuclear Medicine, 3rd edition. Springer Nature Switzerland AG 2024, ISBN 978-3-031-51931-4
European Journal of Nuclear Medicine and Molecular Imaging·2025
Patient’s Tailored Hybrid Imaging and Problem Solving
2025· 1 cited
Ferdinando Calabria, Orazio Schillaci (editors). Radiopharmaceuticals. A guide to PET/CT and PET/MRI, 3rd edition. Springer Nature Switzerland AG 2024. ISBN 978-3-031-54195-7
European Journal of Nuclear Medicine and Molecular Imaging·2024Open Access
660P Atezolizumab plus UCPvax telomerase CD4 TH1-inducer cancer vaccine for the treatment of chemorefractory HPV+ cancers: Safety and efficacy results of the VolATIL phase II study
Annals of Oncology·2024Open Access
page 1 of 26Next →

Frequent Co-authors

Vincenzo Cuccurullo(12), Rodney A. Brooks(7), Pier Francesco Rambaldi(7), Giovanni Di Chiro(6), Norman L. Foster(4), Thomas N. Chase(4), Dikran Bairamian(4), Marco Salvatore(4), Antonio Rotondò(4), Paul Fedio(3), Nicholas J. Patronas(3), Paul L. Kornblith(3), Blair H. Smith(3), Giuseppe Paolisso(3), Giuseppe Lucio Cascini(3), Andrea Ciarmiello(3), Cesare Polito(3), Angela La Manna(3), Laura Evangelista(3), P. F. Rambaldi(3)